BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35400249)

  • 1. Bacteriophage and endolysin engineering for biocontrol of food pathogens/pathogens in the food: recent advances and future trends.
    Lee C; Kim H; Ryu S
    Crit Rev Food Sci Nutr; 2023; 63(27):8919-8938. PubMed ID: 35400249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage Endolysins: Advances in the World of Food Safety.
    Nazir A; Xu X; Liu Y; Chen Y
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review of the applications of bacteriophage-derived endolysins for foodborne bacterial pathogens and food safety: recent advances, challenges, and future perspective.
    Khan FM; Chen JH; Zhang R; Liu B
    Front Microbiol; 2023; 14():1259210. PubMed ID: 37869651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of food matrix on bacteriophage and endolysin antimicrobial efficacy and performance.
    Shannon R; Radford DR; Balamurugan S
    Crit Rev Food Sci Nutr; 2020; 60(10):1631-1640. PubMed ID: 30880427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage-Derived Endolysins Applied as Potent Biocontrol Agents to Enhance Food Safety.
    Chang Y
    Microorganisms; 2020 May; 8(5):. PubMed ID: 32413991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phages and engineered lysins as an effective tool to combat Gram-negative foodborne pathogens.
    Kocot AM; Briers Y; Plotka M
    Compr Rev Food Sci Food Saf; 2023 May; 22(3):2235-2266. PubMed ID: 37009835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.
    Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C
    Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria.
    Khan FM; Rasheed F; Yang Y; Liu B; Zhang R
    Front Pharmacol; 2024; 15():1385261. PubMed ID: 38831886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.
    Liu H; Hu Z; Li M; Yang Y; Lu S; Rao X
    J Biomed Sci; 2023 Apr; 30(1):29. PubMed ID: 37101261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens.
    Basit A; Qadir S; Qureshi S; Rehman SU
    Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-negative endolysins: overcoming the outer membrane obstacle.
    Sisson HM; Jackson SA; Fagerlund RD; Warring SL; Fineran PC
    Curr Opin Microbiol; 2024 Apr; 78():102433. PubMed ID: 38350268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent knowledge in phages, phage-encoded endolysin, and phage encapsulation against foodborne pathogens.
    Yang J; Zhu X; Xu X; Sun Q
    Crit Rev Food Sci Nutr; 2023 Aug; ():1-21. PubMed ID: 37589483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
    Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
    Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
    Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
    Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PlyB Endolysin of Bacteriophage vB_BanS_Bcp1 Exhibits Broad-Spectrum Bactericidal Activity against
    Schuch R; Pelzek AJ; Nelson DC; Fischetti VA
    Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30850428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage therapy in the food industry.
    Endersen L; O'Mahony J; Hill C; Ross RP; McAuliffe O; Coffey A
    Annu Rev Food Sci Technol; 2014; 5():327-49. PubMed ID: 24422588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage endolysins: applications for food safety.
    Schmelcher M; Loessner MJ
    Curr Opin Biotechnol; 2016 Feb; 37():76-87. PubMed ID: 26707470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
    Gerstmans H; RodrĂ­guez-Rubio L; Lavigne R; Briers Y
    Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Advantages and Challenges of Using Endolysins in a Clinical Setting.
    Murray E; Draper LA; Ross RP; Hill C
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33920965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endolysins of bacteriophage vB_Sal-S-S10 can naturally lyse Salmonella enteritidis.
    Wang X; Han L; Rong J; Ren H; Liu W; Zhang C
    BMC Vet Res; 2022 Nov; 18(1):410. PubMed ID: 36411417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.